Sarepta Therapeutics (SRPT) Stock Price Target 2026

The average analyst price target for Sarepta Therapeutics is $24.56, 40.4% above the current price. Of 24 analysts, 9 rate it Buy, 10 Hold and 5 Sell. Targets range from $5 to $80. The latest change came on Nov 6, 2026, when RBC Capital raised its price target on Sarepta Therapeutics from $17 to $18 and kept a Sector Perform rating.